NUTSHELL Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series C1

  • Investors
  • 13

NUTSHELL Therapeutics General Information

Description

Developer of small molecule drugs intended to restore tumor-suppressing functions in patients with solid tumors. The company utilizes big data and artificial intelligence to create a biomedical and chemical data platform that provides bio-modeling & analysis for AI based drug research and development, providing drug developers and research labs with high performing medical research platform.

Contact Information

Website
www.allonutshell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building E, Number 1976, Gaoge Middle Road
  • Pudong New Area
  • Shanghai, 201808
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • Building E, Number 1976, Gaoge Middle Road
  • Pudong New Area
  • Shanghai, 201808
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NUTSHELL Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C1) 15-Sep-2026 Completed Generating Revenue
7. Secondary Transaction - Private 05-Aug-2026 Completed Generating Revenue
6. Later Stage VC (Series A1) 28-Jan-2022 Completed Generating Revenue
5. Later Stage VC (Series A) 10-Jun-2021 Completed Generating Revenue
4. Later Stage VC 14-Dec-2020 Completed Generating Revenue
3. Secondary Transaction - Private 30-Oct-2020 Completed Generating Revenue
2. Later Stage VC 30-Oct-2020 Completed Generating Revenue
1. Later Stage VC 08-Nov-2018 Completed Generating Revenue
To view NUTSHELL Therapeutics’s complete valuation and funding history, request access »

NUTSHELL Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small molecule drugs intended to restore tumor-suppressing functions in patients with solid tumors. The com
Drug Discovery
Shanghai, China
50 As of 2026

Boston, MA
 

Leiden, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NUTSHELL Therapeutics Competitors (3)

One of NUTSHELL Therapeutics’s 3 competitors is HotSpot Therapeutics, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HotSpot Therapeutics Venture Capital-Backed Boston, MA
Anavo Therapeutics Venture Capital-Backed Leiden, Netherlands
Relay Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 3 of 3 competitors. Get the full list »

NUTSHELL Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NUTSHELL Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
CITIC Capital Asset Manager Minority
Decheng Capital Venture Capital Minority
Fortune Capital Venture Capital Minority
Genesis Capital (Hong Kong) Growth/Expansion Minority
Hengxu Capital Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

NUTSHELL Therapeutics FAQs

  • When was NUTSHELL Therapeutics founded?

    NUTSHELL Therapeutics was founded in 2013.

  • Where is NUTSHELL Therapeutics headquartered?

    NUTSHELL Therapeutics is headquartered in Shanghai, China.

  • What is the size of NUTSHELL Therapeutics?

    NUTSHELL Therapeutics has 50 total employees.

  • What industry is NUTSHELL Therapeutics in?

    NUTSHELL Therapeutics’s primary industry is Drug Discovery.

  • Is NUTSHELL Therapeutics a private or public company?

    NUTSHELL Therapeutics is a Private company.

  • What is NUTSHELL Therapeutics’s current revenue?

    The current revenue for NUTSHELL Therapeutics is .

  • How much funding has NUTSHELL Therapeutics raised over time?

    NUTSHELL Therapeutics has raised $75.2M.

  • Who are NUTSHELL Therapeutics’s investors?

    CITIC Capital, Decheng Capital, Fortune Capital, Genesis Capital (Hong Kong), and Hengxu Capital are 5 of 13 investors who have invested in NUTSHELL Therapeutics.

  • Who are NUTSHELL Therapeutics’s competitors?

    HotSpot Therapeutics, Anavo Therapeutics, and Relay Therapeutics are competitors of NUTSHELL Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process